According to a recent article by Tara Lachapelle in Bloomberg, a recent filing by Thermo Fisher Scientific Inc. TMO may suggest the company has something up its sleeves.
The S-3ASR filings, from Tuesday, could imply, according to Lachapelle, that the company is considering dipping its toes into the M&A arena.
It's All Quite Grey
Lachapelle repeatedly emphasized how the filing itself was vague, "detailing how it may or may not issue debt or equity securities in the future that may or may not be used for acquisitions." And a closer look at the filings itself support her ambiguous postulations.
From the filings itself: "An indeterminate amount of the securities of each identified class is being registered as may from time to time be offered hereunder at indeterminate prices, along with an indeterminate number of securities that may be issued upon exercise, settlement, exchange or conversion of securities offered or sold hereunder or that are represented by depository shares.
"Separate consideration may or may not be received for securities that are issuable upon conversion, exercise or exchange of other securities."
Thermo Fisher was recently seen trading up 1 percent on the day at 140.04.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
